#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15060	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2074	720.7	0	.	n	.	0	C451T	SNP	451	451	C	696	696	T	863	T,C	590,218	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15060	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2074	720.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1429	1429	C	873	C	819	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27698	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3671	752.7	0	.	n	.	0	T695C	SNP	695	695	T	1055	1055	C	830	C,T	780,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27698	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3671	752.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2331	2331	C	887	C,T	822,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27698	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3671	752.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2405	2405	A	881	A	836	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27698	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3671	752.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2957	2957	C	840	C	796	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27698	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3671	752.7	0	HET	.	.	.	C29T,A	.	29	29	C	389	389	C	903	C,T,A	686,163,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27698	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3671	752.7	0	HET	.	.	.	A1638G	.	1638	1638	A	1998	1998	A	901	A,G	456,403	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1998	folP	855	855	100.0	folP.l15.c4.ctg.1	1505	132.2	1	SNP	p	R229S	1	.	.	685	687	AGC	1039	1041	AGC	210;209;209	A;G;C	196;194;195	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5216	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3412	152.4	1	SNP	p	S91F	1	.	.	271	273	TTC	614	616	TTC	165;162;161	T;T;C	156;154;151	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5216	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3412	152.4	1	SNP	p	D95G	1	.	.	283	285	GGC	626	628	GGC	165;163;160	G,T;G;C	153,1;152;151	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5216	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3412	152.4	1	SNP	p	G95N	0	.	.	283	285	GGC	626	628	GGC	165;163;160	G,T;G;C	153,1;152;151	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1622	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1418	114.1	1	SNP	p	G45D	0	.	.	133	135	GGC	605	607	GGC	216;216;216	G;G;C,A	203;202;203,1	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	802	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1020	78.4	0	.	n	.	0	A197.	DEL	197	197	A	534	534	A	210	A	197	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5984	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2981	200.0	1	SNP	p	D86N	0	.	.	256	258	GAC	593	595	GAC	244;242;242	G;A;C	231;226;233	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5984	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2981	200.0	1	SNP	p	R87I	0	.	.	259	261	CGT	596	598	CGT	240;240;241	C,A;G;T	230,2;230;232	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5984	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2981	200.0	1	SNP	p	R87W	0	.	.	259	261	CGT	596	598	CGT	240;240;241	C,A;G;T	230,2;230;232	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5984	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2981	200.0	1	SNP	p	S87R	1	.	.	259	261	CGT	596	598	CGT	240;240;241	C,A;G;T	230,2;230;232	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5984	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2981	200.0	1	SNP	p	S88P	0	.	.	262	264	TCC	599	601	TCC	240;238;241	T;C;C	227;231;233	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4220	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2594	162.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1443	1445	GGC	221;218;218	G;G;C	207;204;201	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3794	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2552	148.1	1	SNP	p	A311V	0	.	.	931	933	GCC	1308	1310	GCC	192;197;198	G;C;C	181;185;185	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3794	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2552	148.1	1	SNP	p	I312M	1	.	.	934	936	ATG	1311	1313	ATG	198;196;191	A;T;G	185;184;180	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3794	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2552	148.1	1	SNP	p	V316T	1	.	.	946	948	ACC	1323	1325	ACC	195;200;199	A;C;C	182;187;186	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3794	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2552	148.1	1	SNP	p	T316P	0	.	.	946	948	ACC	1323	1325	ACC	195;200;199	A;C;C	182;187;186	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3794	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2552	148.1	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1824	1826	ACC	212;215;217	A;C;C	191;201;201	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3794	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2552	148.1	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1878	1880	GCG	239;241;241	G;C;G	223;223;225	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3794	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2552	148.1	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1878	1880	GCG	239;241;241	G;C;G	223;223;225	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3794	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2552	148.1	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2001	2003	GGT	161;158;161	G;G;T	146;145;146	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3794	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2552	148.1	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2010	2012	AGC	158;154;152	A;G;C	144;138;136	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3794	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2552	148.1	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2028	2030	CCG	130;133;138	C,G;C;G,C	99,5;100;108,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5892	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3098	189.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1585	1587	CCG	211;211;209	C;C;G	194;197;190	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2454	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1927	126.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	607	607	C	170	C	157	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3010	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1680	178.3	0	.	p	.	0	E41K	NONSYN	121	123	GAA	442	444	AAA	231;228;229	A;A;A	223;222;222	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3010	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1680	178.3	1	SNP	p	G120K	1	.	.	358	360	AAG	679	681	AAG	242;240;237	A;A;G	228;227;221	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3010	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1680	178.3	1	SNP	p	A121N	1	.	.	361	363	AAC	682	684	AAC	240;243;242	A;A;C	224;227;225	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3010	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1680	178.3	1	SNP	p	N121D	0	.	.	361	363	AAC	682	684	AAC	240;243;242	A;A;C	224;227;225	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11222	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4859	230.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1214	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1014	118.9	1	SNP	p	V57M	1	.	.	169	171	ATG	455	457	ATG	268;272;264	A;T;G	251;253;248	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
